Assignee
VOYAGER THERAPEUTICS INC
US·40 granted patents·82 pending applications·136 citations·filing 2015–2025
Top patents by PatentIndex Score
122 records- 0197US11193129B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2020·Granted Dec 7, 2021·8 cites·20 claims
- 0296US11326182B2Compositions for the treatment of diseaseVOYAGER THERAPEUTICS INC·Filed 2017·Granted May 10, 2022·18 cites·24 claims
- 0396US10920227B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2020·Granted Feb 16, 2021·8 cites·22 claims
- 0496US10584337B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2017·Granted Mar 10, 2020·15 cites·28 claims
- 0595US11198873B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2020·Granted Dec 14, 2021·7 cites·22 claims
- 0694US11603542B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2018·Granted Mar 14, 2023·7 cites·28 claims
- 0794US11542506B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·3 cites·30 claims
- 0894US10597660B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2015·Granted Mar 24, 2020·11 cites·27 claims
- 0994US10570395B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2015·Granted Feb 25, 2020·13 cites·22 claims
- 1094US10335466B2AADC polynucleotides for the treatment of parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2015·Granted Jul 2, 2019·11 cites·14 claims
- 1193US11859200B2AAV capsids with increased tropism to brain tissueVOYAGER THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·5 cites·25 claims
- 1292US11434502B2Treatment of amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2018·Granted Sep 6, 2022·5 cites·16 claims
- 1392US11027000B2AADC polynucleotides for the treatment of Parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2019·Granted Jun 8, 2021·4 cites·26 claims
- 1491US10577627B2Chimeric capsidsVOYAGER THERAPEUTICS INC·Filed 2015·Granted Mar 3, 2020·6 cites·28 claims
- 1589US12296025B2AAV capsid variants and uses thereofVOYAGER THERAPEUTICS INC·Filed 2024·Granted May 13, 2025·3 cites·30 claims
- 1689US11752181B2Compositions and methods of treating Huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2018·Granted Sep 12, 2023·4 cites·21 claims
- 1788US2025146000A1Compositions and methods of treating amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1888US2024415943A1Aadc polynucleotides for the treatment of parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1987US11512327B2Compositions and methods for delivery of AAVVOYAGER THERAPEUTICS INC·Filed 2018·Granted Nov 29, 2022·3 cites·24 claims
- 2086US11931375B2Treatment of amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2022·Granted Mar 19, 2024·1 cites·24 claims
- 2186US2025115917A1Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2284US12123002B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2022·Granted Oct 22, 2024·0 cites·20 claims
- 2383US12577588B2AAV capsids with increased tropism to brain tissueVOYAGER THERAPEUTICS INC·Filed 2023·Granted Mar 17, 2026·0 cites·30 claims
- 2482US11759506B2AADC polynucleotides for the treatment of Parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2019·Granted Sep 19, 2023·2 cites·18 claims
- 2581US2025084435A1Treatment of amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2678US2024285667A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2777US12116589B2Treatment of amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2022·Granted Oct 15, 2024·0 cites·20 claims
- 2877US12084659B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·0 cites·24 claims
- 2977US11975056B2AADC polynucleotides for the treatment of Parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·24 claims
- 3077US2024415868A1Compositions and methods for treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3177US2024325427A1Treatment of amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3276US12305189B2Compositions and methods for delivery of AAVVOYAGER THERAPEUTICS INC·Filed 2022·Granted May 20, 2025·0 cites·6 claims
- 3376US12071625B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2021·Granted Aug 27, 2024·0 cites·23 claims
- 3476US2026035689A1Redirection of tropism of aav capsidsVOYAGER THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3575US2024226203A9Compositions and methods of treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3674US12146150B2Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous deliveryVOYAGER THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
- 3774US11497576B2Trajectory array guide systemVOYAGER THERAPEUTICS INC·Filed 2018·Granted Nov 15, 2022·2 cites·40 claims
- 3872US12419969B2AAV capsid variants and uses thereofVOYAGER THERAPEUTICS INC·Filed 2025·Granted Sep 23, 2025·0 cites·30 claims
- 3972US2023399642A1Compositions and methods of treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4072US2023295663A1Compositions and methods of treating amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4171US2025090197A1Cannula system and use thereofVOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4270US2019008933A1Aadc polynucleotides for the treatment of parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4370US2019008931A1Aadc polynucleotides for the treatment of parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4470US2019008932A1Aadc polynucleotides for the treatment of parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4570US2022389449A1Compositions for the treatment of diseaseVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4669US2022195459A1Regulatable expression using adeno-associated virus (aav)VOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4769US2025001012A1Aav capsid variants and uses thereofVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4868US12467046B2Redirection of tropism of AAV capsidsVOYAGER THERAPEUTICS INC·Filed 2019·Granted Nov 11, 2025·0 cites·29 claims
- 4968US2022395544A1Compositions for the treatment of diseaseVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 5067US12180500B2Chimeric capsidsVOYAGER THERAPEUTICS INC·Filed 2020·Granted Dec 31, 2024·0 cites·10 claims
Showing the top 50 of 122 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when VOYAGER THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →